Search Results - "Parambi, Della Grace Thomas"
-
1
Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool
Published in Environmental science and pollution research international (01-06-2020)“…Cancer remains as the major cause of death worldwide. The main reason why available therapies fail is that a vicious cycle in established which initiates…”
Get full text
Journal Article -
2
FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years
Published in RSC advances (29-08-2024)“…Dimethylamine (DMA) derivatives represent a promising class of compounds with significant potential in the field of medicinal chemistry. DMA derivatives…”
Get full text
Journal Article -
3
A New Potent and Selective Monoamine Oxidase‐B Inhibitor with Extended Conjugation in a Chalcone Framework: 1‐[4‐(Morpholin‐4‐yl)phenyl]‐5‐phenylpenta‐2,4‐dien‐1‐one
Published in ChemMedChem (03-09-2020)“…The general blueprint for the design of monoamine oxidase‐B (MAO‐B) inhibitors has been based on two phenyl or heteronuclei linked via a spacer of appropriate…”
Get full text
Journal Article -
4
The Role of Mitochondrial Genes in Neurodegenerative Disorders
Published in Current neuropharmacology (01-01-2022)“…Mitochondrial disorders are clinically heterogeneous, resulting from nuclear gene and mitochondrialmutations that disturb the mitochondrial functions and…”
Get full text
Journal Article -
5
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors
Published in MedChemComm (01-11-2018)“…A series of 13 phenyl substituted thiosemicarbazones ( ) were synthesized and evaluated for their inhibitory potential towards human recombinant monoamine…”
Get full text
Journal Article -
6
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
Published in Drug design, development and therapy (01-02-2020)“…Histone deacetylases (HDACs) represent one of the most validated cancer targets. The inhibition of HDACs has been proven to be a successful strategy for the…”
Get full text
Journal Article -
7
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Published in European journal of medicinal chemistry (15-11-2019)“…Drug discovery and development are long and financially taxing processes. On an average it takes 12–15 years and costs 1.2 billion USD for successful drug…”
Get full text
Journal Article -
8
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Published in Journal of pharmacy and pharmacology (01-09-2019)“…Objectives Considerable progress has been made in the treatment of Alzheimer’s disease (AD), but all available strategies focus on alleviating symptoms rather…”
Get full text
Journal Article -
9
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
Published in Molecular neurobiology (01-01-2022)“…The etiology of many neurological diseases affecting the central nervous system (CNS) is unknown and still needs more effective and specific therapeutic…”
Get full text
Journal Article -
10
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives
Published in Archiv der Pharmazie (Weinheim) (01-08-2024)“…Quinazoline and quinazolinone derivatives piqued medicinal chemistry interest in developing novel drug candidates owing to their pharmacological potential…”
Get full text
Journal Article -
11
Ameliorative effect of ethoxylated chalcone-based MAO-B inhibitor on behavioural predictors of haloperidol-induced Parkinsonism in mice: evidence of its antioxidative role against Parkinson’s diseases
Published in Environmental science and pollution research international (2022)“…Parkinson’s disease is a progressive neurodegenerative disorder that affects mostly elderly people above the age of 60. Previously, we have reported that the…”
Get full text
Journal Article -
12
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study
Published in Computational biology and chemistry (01-08-2023)“…Oximes are the promising structural scaffold for inhibiting monoamine oxidase (MAO)-B. Eight chalcone-based oxime derivatives were synthesized by…”
Get full text
Journal Article -
13
A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO‐B Inhibitors [2015‐Till Date]
Published in ChemistrySelect (Weinheim) (18-07-2024)“…Molecular dynamics (MD) simulation is an in silico method used in the biomolecular level of research to study how the protein interacts with the target with…”
Get full text
Journal Article -
14
Recent Progress in Synthetic and Natural Catechol‑O‑methyltransferase Inhibitors for Neurological Disorders
Published in ACS omega (05-11-2024)“…Catechol-O-methyltransferase (COMT) inhibitors have played a crucial role in the development of potent and selective drugs for the treatment of Parkinson’s…”
Get full text
Journal Article -
15
Studies on the interaction between HSA and new halogenated metformin derivatives: influence of lipophilic groups in the binding ability
Published in Journal of biomolecular structure & dynamics (02-05-2020)“…In the type II diabetes mellitus, Metformin hydrochloride is recommended as a common FAD approved drug. Synthesis of novel metformin series has been widely…”
Get full text
Journal Article -
16
Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase‑B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry
Published in ACS omega (08-03-2022)“…Fifteen multiconjugated dienones (MK1–MK15) were synthesized and evaluated to determine their inhibitory activities against monoamine oxidases (MAOs) A and B…”
Get full text
Journal Article -
17
Screening and Molecular Docking of Bioactive Metabolites of the Red Sea Sponge Callyspongia siphonella as Potential Antimicrobial Agents
Published in Antibiotics (Basel) (23-11-2022)“…Marine sponges create a wide range of bioactive secondary metabolites, as documented throughout the year. Several bioactive secondary metabolites were isolated…”
Get full text
Journal Article -
18
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Published in Brain research bulletin (01-07-2020)“…•Blood brain barrier − structure, molecular composition, and physiology.•Transportation across the blood-brain barrier.•Blood-brain barrier dysfunction and…”
Get full text
Journal Article -
19
Enzyme Inhibition Assays for Monoamine Oxidase
Published in Methods in molecular biology (Clifton, N.J.) (2024)“…Monoamine oxidase (MAO) catalyzes the oxidative deamination of monoamines with two isoforms, namely, MAO-A and MAO-B, in mitochondrial outer membranes. These…”
Get more information
Journal Article -
20
Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson’s Disease
Published in Neurochemical research (01-11-2020)“…Parkinson’s disease (PD) is a neurodegenerative disorder of dopaminergic, noradrenergic, and serotonergic systems, in which dopamine, noradrenaline, and…”
Get full text
Journal Article